Is it the Right Time to Add Phibro Stock to Your Portfolio?

PAHC's Animal Health gains from MFA, vaccine and mineral nutrition growth, but tariffs, costs and currency swings remain key risks to its outlook.

Zacks Investment Research • Oct 8, 2026

PAHC vs. HAE: Which Stock Is the Better Value Option?

Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Oct 5, 2026

Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Investment Research • Sep 28, 2026

Why Is Phibro (PAHC) Down 6.7% Since Last Earnings Report?

Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?

Zacks Investment Research • Sep 25, 2026

Best Momentum Stocks to Buy for September 21st

SEI, SDRL and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on September 21st, 2026.

Zacks Investment Research • Sep 21, 2026

PAHC vs. HAE: Which Stock Should Value Investors Buy Now?

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Haemonetics (HAE). But which of these two stocks presents investors with the better value opportunity right now?

Zacks Investment Research • Sep 18, 2026

Phibro Animal Health (PAHC) is a Top-Ranked Value Stock: Should You Buy?

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Sep 17, 2026

4 Stocks With Strong Interest Coverage to Buy as Yields Rise

DiamondRock Hospitality, Vertiv, Mueller Water Products and Phibro Animal Health stand out for strong interest coverage as Treasury yields rise.

Zacks Investment Research • Sep 16, 2026

Does Phibro (PAHC) Have the Potential to Rally 25.77% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 25.8% in Phibro (PAHC). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Sep 14, 2026

Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Sep 11, 2026